MSF asks Regeneron to make COVID antibody cocktail affordable; forego patent claims

MSF asks Regeneron to make COVID antibody cocktail affordable; forego patent claims Regenron has priced the antiviral cocktail at $820 (Rs 59,750) in India, $2,000 in Germany and $2,100 in the US. It has also filed patent applications in at least 11 low= and middle-income countries

No comments:

Post a Comment